These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 33210109)

  • 1. Recent trends for the management of diabetes for older adults in the context of universal coverage and COVID-19: evidence from Mexico.
    Arredondo A
    Int Health; 2021 Sep; 13(5):488-491. PubMed ID: 33210109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent trends for the management of hypertension in older adults in Latin America in the context of universal coverage: Evidence from Mexico.
    Arredondo A; Recamán AL; Suarez-Herrera JC; Cuadra SM
    Int J Health Plann Manage; 2021 Mar; 36(2):579-586. PubMed ID: 33368667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health disparities from economic burden of diabetes in middle-income countries: evidence from México.
    Arredondo A; Reyes G
    PLoS One; 2013; 8(7):e68443. PubMed ID: 23874629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges on the epidemiological and economic burden of diabetes and hypertension in Mexico.
    Arredondo A; Orozco E; Alcalde-Rabanal J; Navarro J; Azar A
    Rev Saude Publica; 2018; 52():23. PubMed ID: 29489993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The cost of diabetes in Latin America: evidence from Mexico].
    Arredondo A; De Icaza E
    Value Health; 2011; 14(5 Suppl 1):S85-8. PubMed ID: 21839907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends and challenges in diabetes for middle-income countries: Evidence from Mexico.
    Arredondo A; Orozco E; Duarte MB; Cuadra M; Recaman AL; Azar A
    Glob Public Health; 2019 Feb; 14(2):227-240. PubMed ID: 30068257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiological and financial indicators of hypertension in older adults in Mexico: challenges for health planning and management in Latin America.
    Arredondo A; Duarte MB; Cuadra SM
    Int J Health Plann Manage; 2017 Apr; 32(2):e121-e136. PubMed ID: 27238949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costs and epidemiological changes of chronic diseases: implications and challenges for health systems.
    Arredondo A; Aviles R
    PLoS One; 2015; 10(3):e0118611. PubMed ID: 25781625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health care costs and financial consequences of epidemiological changes in chronic diseases in Latin America: evidence from Mexico.
    Arredondo A; Zúñiga A; Parada I
    Public Health; 2005 Aug; 119(8):711-20. PubMed ID: 15885723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of survival after severe acute respiratory syndrome coronavirus 2 infection in Mexican outpatients and hospitalised patients.
    Prado-Galbarro FJ; Sanchez-Piedra C; Gamiño-Arroyo AE; Cruz-Cruz C
    Public Health; 2020 Dec; 189():66-72. PubMed ID: 33166857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic consequences of epidemiological changes in diabetes in middle-income countries: the Mexican case.
    Arredondo A; Zúñiga A
    Diabetes Care; 2004 Jan; 27(1):104-9. PubMed ID: 14693974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges and dilemmas on universal coverage for non-communicable diseases in middle-income countries: evidence and lessons from Mexico.
    Arredondo A; Azar A; Recaman AL
    Global Health; 2018 Aug; 14(1):89. PubMed ID: 30143010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diabetes and hypertension as factors associated with Covid-19 lethality in Sonora, Mexico, 2020].
    Álvarez-López DI; Espinoza-Molina MP; Cruz-Loustaunau ID; Álvarez-Hernández G
    Salud Publica Mex; 2020; 62(5):456-457. PubMed ID: 33027852
    [No Abstract]   [Full Text] [Related]  

  • 14. Projecting diabetes prevalence among Mexicans aged 50 years and older: the Future Elderly Model-Mexico (FEM-Mexico).
    Gonzalez-Gonzalez C; Tysinger B; Goldman DP; Wong R
    BMJ Open; 2017 Oct; 7(10):e017330. PubMed ID: 29074514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico.
    Bello-Chavolla OY; Bahena-López JP; Antonio-Villa NE; Vargas-Vázquez A; González-Díaz A; Márquez-Salinas A; Fermín-Martínez CA; Naveja JJ; Aguilar-Salinas CA
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32474598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges of the epidemiological and economic burdens associated with hypertension in middle income countries: evidence from Mexico.
    Arredondo A; Cuadra SM; Duarte MB
    BMC Public Health; 2015 Nov; 15():1106. PubMed ID: 26546356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Universal Drug Coverage and Socioeconomic Disparities in Health Care Costs Among Persons With Diabetes.
    Isaranuwatchai W; Fazli GS; Bierman AS; Lipscombe LL; Mitsakakis N; Shah BR; Wu CF; Johns A; Booth GL
    Diabetes Care; 2020 Sep; 43(9):2098-2105. PubMed ID: 32641377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caring for Older Adults With Diabetes During the COVID-19 Pandemic.
    Sy SL; Munshi MN
    JAMA Intern Med; 2020 Sep; 180(9):1147-1148. PubMed ID: 32658279
    [No Abstract]   [Full Text] [Related]  

  • 19. COVID-19 Pandemic: An Opportunity for Universal Health Coverage.
    Ranabhat CL; Jakovljevic M; Kim CB; Simkhada P
    Front Public Health; 2021; 9():673542. PubMed ID: 34395361
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of age on the association between diabetes and mortality in adult patients with COVID-19 in Mexico.
    Woolcott OO; Castilla-Bancayán JP
    Sci Rep; 2021 Apr; 11(1):8386. PubMed ID: 33863997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.